Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran

Saudi Medical Journal

Volumn 29, Issue 1, 2008, Pages 148-150

  Tabarsi, Payam ^a   Baghaei, Parvaneh ^a   Mirsaeidi, Mehdi ^a   Amiri, Majid ^a   Alipanah, Narges ^a   Emami, Habib ^a   Novin, Atieh ^a   Mansouri, Davood ^a   Masjedi, Mohammad R ^a   Velayati, Ali A ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; LAMIVUDINE; NELFINAVIR; PYRAZINAMIDE; PYRIDOXINE; RIFABUTIN; RIFAMPICIN; ZIDOVUDINE; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC SENSITIVITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRAN; MAJOR CLINICAL STUDY; MIXED INFECTION; RETROSPECTIVE STUDY; SEROLOGY; SPUTUM CULTURE; SPUTUM SMEAR; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT OUTCOME; TUBERCULOSIS; VENEREAL DISEASE REACTION TEST; WESTERN BLOTTING; ADULT; AIDS RELATED COMPLEX; CHI SQUARE DISTRIBUTION; FEMALE; MALE; SURVIVAL RATE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBIOTICS, ANTITUBERCULAR; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IRAN; MALE; RIFABUTIN; SURVIVAL RATE; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 40949158014     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Corbett EL, Watt CJ, Walker N, Maher D. Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021.
2. Sonneberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. HIV and pulmonary tuberculosis: The impact goes beyond those infected with HIV. AIDS 2004; 18: 657-662.
3. Maher D, Harries A, Getahun H. Tuberculosis and HIV interaction in sub-saharan Africa:iMpact on patients and programmes; implication for policies. Trop Med Ins Health 2005; 8: 734-742.
4. Wood E. Hogg RS. Yip B, Harrigan PR, Montaner JS, Using baseline CD4 cell count and plasma HIV RNA to guide the initiation of highly active antiretroviral therapy. Rev Invest Clin 2004; 56: 232-236.
5. Sungka nuparph S, Manosuthi W. Kiertiburanakul S, Vibhagool A, Initiation of antiretroviral therapy in advance AIDS with active tuberculosis Clinical experiences from Thailand. J Infect 2006; 52: 188-194.